tiprankstipranks
Trending News
More News >
Pfizer Inc (PFE)
NYSE:PFE
US Market

Pfizer (PFE) Drug Pipeline

Compare
35,968 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Pf-07275315 Dose 1, Pf-07275315-Dose 2, Pf-07275315-Dose 3
Moderate To Severe Chronic Obstructive Pulmonary Disease
Phase III
Not Yet Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Jan 22, 2026
Itraconazole, Pf-07248144
Healthy Adult Participants
Phase I
Recruiting
A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine)
Jan 05, 2026
C.Difficile Vaccine
Clostridioides Difficile Associated Disease
Phase III
Recruiting
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Dec 05, 2025
Test Formulation, Reference Formulation
Healthy Volunteer
Phase I
Recruiting
A Study to Compare Blood Levels of Two Different Dosage Formulations of the Study Medicine Called CGRP Receptor Antagonist in Healthy Adults
Nov 21, 2025
Pf-07985631
Healthy
Phase I
Not Yet Recruiting
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults
Nov 14, 2025
Ibuzatrelvir
Healthy Participant
Phase I
Completed
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults
Nov 14, 2025
Pf-08065010
Healthy
Phase I
Not Yet Recruiting
A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults
Nov 14, 2025
Prazosin Hcl
Healthy
Phase I
Recruiting
A Study to Learn How Different Forms of the Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults
Nov 13, 2025
Ipilimumab, Pf-08634404
Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Unresectable Hepatocellular Carcinoma
Phase I/II
Recruiting
A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Nov 07, 2025
Atezolizumab, Chemotherapy, Pf-08634404
Small Cell Lung Cancer (Sclc)
Phase II/III
Recruiting
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Nov 07, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Pfizer Inc (PFE) have in its pipeline
      PFE is currently developing the following drugs: Pf-07275315 Dose 1, Pf-07275315-Dose 2, Pf-07275315-Dose 3, Itraconazole, Pf-07248144, C.Difficile Vaccine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.